Effects of allisartan-isoproxil-based combination antihypertensive regimen in hypertensive patients with microalbuminuria or hyperuricemia.

Authors:
Sun N; Wang H.

Journal:
J Clin Hypertens (Greenwich)

Publication Year: 2024

DOI:
10.1111/jch.14773

PMCID:
PMC10918723

PMID:
38319613

View on PubMed View on PMC View Publisher

Journal Information

Journal Title: J Clin Hypertens (Greenwich)

Detailed journal information not available.

Publication Details

Subject Category: Peripheral Vascular Disease

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score

3/6

50.0% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Code Sharing

COI Disclosure

Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT The study expenses and drugs were provided by Shenzhen Salubris Pharmaceuticals Co., Ltd. The authors did not participate in the company's drug promotions or accept any unwarranted payments."

Funding Disclosure

Protocol Registration

Evidence found in paper:

"This study was registered on the Registration and Information Disclosure Platform for China Drug Clinical Studies (http://www.chinadrugtrials.org.cn/index.html) before the inclusion of the first patient. Project Registration No.: CTR20160138."

Open Access

Paper is freely available to read

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025